The correlation between platelet activation markers and HMGB1 in patients with disseminated intravascular coagulation and hematologic malignancy

Platelets

Volumn 22, Issue 5, 2011, Pages 396-397

  Nomura, Shosaku ^a   Fujita, Shinya ^a   Ozasa, Ryotaro ^a   Nakanishi, Takahisa ^a   Miyaji, Michihiko ^a   Mori, Shinichiro ^a   Ito, Tomoki ^a   Ishii, Kazuyoshi ^b  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

^b Kishiwada City Hospital   (Japan)

Author keywords

DIC; hematologic malignancy; HMGB1; Microparticle; recombinant; thrombomodulin

Indexed keywords

C REACTIVE PROTEIN; CD40 LIGAND; FIBRINOGEN; HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; RECOMBINANT THROMBOMODULIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; CLINICAL ARTICLE; DISEASE ASSOCIATION; DISSEMINATED INTRAVASCULAR CLOTTING; FEMALE; FIBRINOGEN BLOOD LEVEL; HEMATOLOGIC MALIGNANCY; HUMAN; LETTER; MALE; PLATELET MICROPARTICLE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTHROMBIN TIME; THROMBOCYTE ACTIVATION;

ADULT; AGED; BIOLOGICAL MARKERS; BLOOD PLATELETS; CYTOKINES; DISSEMINATED INTRAVASCULAR COAGULATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMATOLOGIC NEOPLASMS; HMGB1 PROTEIN; HUMANS; JAPAN; MALE; MIDDLE AGED; PLATELET ACTIVATION; PLATELET COUNT; THROMBOMODULIN; TREATMENT OUTCOME;

EID: 80051523641     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.3109/09537104.2011.553970     Document Type: Letter

References (11)

1. Levi M, Ten Cate H. Disseminated intravascular coagulations. N Eng J Med 1999;341:586-592.
2. Toh CH, Dennis M. Disseminated intravascular coagulations: Old disease, new hope. BMJ 2003;327:974-977. (Pubitemid 37330403)
3. Lundahl TH, Lindahl TL, Fagerberg IH, Egberg N, Bunescu A, Larsson A. Activated platelets and impared platelet function in intensive care patients analyzed by flow cytometry. Blood Coagul Fibrinolysis 1996;7:218-220. (Pubitemid 26178109)
4. Yaguchi A, Lobo FLM, Vincent JL, Pradier O. Platelet function in sepsis. J Thromb Haemost 2004;2:2096-2102. (Pubitemid 40185767)
5. Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002;418:191-195. (Pubitemid 34773774)
6. Fiuza C, Bustin M, Talwar S, Tropea M, Gerstenberger E, Shelhamer JH, Suffiedini AF. Inflammation-promorting activity of HMGB1 on human microvascular endothelial cells. Blood 2003;101:2652-2660. (Pubitemid 36857626)
7. Abeyama K, Stern DM, Ito Y, Kawahara K, Yoshimoto Y, Tanaka M, et al. The N-terminal domain of thrombomodulin sequesters high-mobility group-B1 protein, a novel anti-inflammatory mechanism. J Clin Invest 2005;115:1267-1274. (Pubitemid 40629045)
8. Hatada T, Wada H, Nobori T, Okabayashi K, Maruyama K, Abe Y, et al. Plasma concentrationsand importance of High Mobility Group Box protein in the prognosis of organ failure in patients with disseminated intravascular coagulation. Thromb Haemost 2005;94:975-979. (Pubitemid 41645937)
9. Kobayashi N, Maekawa T, Takada M, Tanaka H, Gonmori H. Criteria for diagnosis of DIC based on the analysis of clinical and laboratory findings in 345 DIC patients collected by the Research Committee on DIC in Japan. Bibl Hematol 1983;49:265-275. (Pubitemid 14202230)
10. Shebuski RJ, Kilgore KS. Role of inflammatory mediator in thrombogenesis. J Pharmacol Exp Ther 2002;300:729-735.
11. Nomura S, Ozaki Y, Ikeda Y. Function and role of microparticles in various clinical settings. Thromb Res 2008; 123:8-23.